Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  New England Journal of Medicine

• Publication date

  1988-06-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM198806093182304PMID 3285215
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The long-term course of cyclosporine-associated chronic nephropathy.

  1988cited by this paper
• Reversibility of airflow obstruction.

  1988cited by this paper
• Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation.

  1987cited by this paper
• Adverse effects of low-dose azathioprine on Australian primary graft survival (1978-1984).

  1987cited by this paper
• Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients.

  1987cited by this paper
• Management of immunosuppressive problems in renal allograft recipients.

  1987cited by this paper
• Adverse effects of low-dose azathioprine on Australian primary graft survival (1978-1984).

  1987cited by this paper
• Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

  1987cited by this paper
• Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine.

  1987cited by this paper
• Renal histopathologic alterations in patients treated with cyclosporine for uveitis.

  1986cited by this paper
• Side effects of cyclosporin A treatment in patients with rheumatoid arthritis.

  1986cited by this paper
• A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.

  1986cited by this paper
• Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients.

  1985cited by this paper
• Reversibility of cyclosporin nephrotoxicity after three months' treatment.

  1985cited by this paper
• Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine.

  1985cited by this paper
• Conversion from cyclosporine to azathioprine in renal graft recipients.

  1985cited by this paper
• Pharmacologic aspects of cyclosporine therapy: pharmacokinetics.

  1985cited by this paper
• The case against conversion to azathioprine in cyclosporine-treated renal recipients.

  1985cited by this paper
• Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation.

  1985cited by this paper
• Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation.

  1985cited by this paper
• Renal function in patients with autoimmune diseases treated with cyclosporine.

  1985cited by this paper
• CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE IN RENAL ALLOGRAFT RECIPIENTS

  1984cited by this paper
• A prospective randomized trial of matching for HLA-A and B versus HLA-DR in renal transplantation.

  1984cited by this paper
• A PROSPECTIVE RANDOMIZED TRIAL OF LOW‐DOSE VERSUS HIGH‐DOSE STEROIDS IN CADAVERIC RENAL TRANSPLANTATION

  1984cited by this paper
• Renal biopsy morphology in renal transplantation: A comparative study of the light‐microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin

  1984cited by this paper
• Cyclosporine-associated chronic nephropathy.

  1984cited by this paper
• Cyclosporine: five years' experience in cadaveric renal transplantation.

  1984cited by this paper
• Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial.

  1983cited by this paper
• A randomized clinical trial of cyclosporine in cadaveric renal transplantation.

  1983cited by this paper
• A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months.

  1983cited by this paper
• Delayed complications of renal transplantation and their prevention

  1982cited by this paper
• [Basic immunosuppressive therapy following kidney transplantation. Cyclosporin A in combination with small doses of methylprednisolone, without regard to selection criteria. Preliminary report].

  1982cited by this paper
• Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

  1979cited by this paper
• MEDICINE IN THE OPEN UNIVERSITY

  1975cited by this paper
• Letter: Jaundice associated with norethisterone-acetate treatment of breast cancer.

  1975cited by this paper
• Antilymphocyte globulin in patients with renal allografts from cadaveric donors. Late results of a controlled trail.

  1973cited by this paper
• Living organisms in patent law.

  1970cited by this paper

• Stem Cell Therapy in Parkinson’s Disease: Advances in Regenerative Medicine and Clinical Applications

  2025cites this paper
• The history of uveitis: from antiquity to the present day

  2024cites this paper
• Global Perspective on Kidney Transplantation: Australia.

  2021cites this paper
• Closing the gap between evidence and practice in chronic kidney disease.

  2017cites this paper
• Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.

  2017cites this paper
• Safety of Immunosuppressive Drugs Used as Maintenance Therapy in Kidney Transplantation: A Systematic Review and Meta-Analysis

  2013influential citation
• Mycophenolate Mofetil

  2012cites this paper
• Comparative models of transplant and non-transplant human kidney disease

  2012cites this paper
• Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation.

  2011cites this paper
• Long-term cancer risk of immunosuppressive regimens after kidney transplantation.

  2010cites this paper
• A clinical scoring system highly predictive of long-term kidney graft survival.

  2010cites this paper
• Immunosuppressive Drugs in Kidney Transplantation

  2009cites this paper
• Use of tacrolimus in Chinese renal transplant recipients

  2009cites this paper
• Cyclosporine Withdrawal Improves Long-Term Graft Survival in Renal Transplantation

  2009cites this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients.

  2009influential citation
• Sirolimus Conversion in Liver Transplant Recipients With Renal Dysfunction: A Prospective, Randomized, Single-Center Trial

  2007cites this paper
• Current and evolving immunosuppressive regimens in kidney transplantation.

  2006cites this paper
• Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk

  2006cites this paper
• A Hemifacial Transplantation Model in Rabbits

  2006cites this paper
• Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?

  2006cites this paper
• Paired kidney analysis of tacrolimus and cyclosporine microemulsion‐based therapy in Chinese cadaveric renal transplant recipients

  2006cites this paper
• Calcineurin Inhibitor Withdrawal in Stable Kidney Transplant Patients Decreases the Donor-Specific Cytotoxic T Lymphocyte Precursor Frequency

  2005cites this paper
• Role of altered prednisolone-specific lymphocyte sensitivity in chronic renal failure as a pharmacodynamic marker of acute allograft rejection after kidney transplantation

  2004cites this paper
• Benefit-Risk Assessment of Ciclosporin Withdrawal in Renal Transplant Recipients

  2004cites this paper
• Nocardial infection in immunosuppressed kidney transplant recipients

  2004cites this paper
• A Randomized Controlled Trial of Cyclosporine Withdrawal in Renal-Transplant Recipients: 15-Year Results

  2004cites this paper
• The effect of rapamycin after cyclosporin dose reduction on chronic allograft nephropathy

  2003cites this paper
• A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts1

  2003cites this paper
• Long-term effects of nonimmune tissue injury in renal transplantation

  2002cites this paper
• Cyclosporine withdrawal from a mycophenolate mofetil–containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study1,2

  2002cites this paper
• Down‐regulated donor‐specific T‐cell reactivity during successful tapering of immunosuppression after kidney transplantation

  2002cites this paper
• Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen.

  2002cites this paper
• New developments in immunosuppressive therapy in renal transplantation

  2002cites this paper
• Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients

  2002cites this paper
• Tailoring therapy: balancing toxicity and chronic allograft dysfunction.

  2001cites this paper
• Mycophenolate mofetil: suggested guidelines for use in kidney transplantation.

  2001cites this paper
• Single‐center experience with tacrolimus versus cyclosporine‐Neoral in renal transplant recipients

  2001cites this paper
• Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.

  2001cites this paper
• Clinical Trials in Transplant Immunosuppression: What Have We Learned?

  2001cites this paper
• Chronic graft dysfunction: donor factors.

  2001cites this paper
• Adverse Gastrointestinal Effects of Mycophenolate Mofetil

  2001cites this paper
• Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy

  2001cites this paper
• Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients

  2001cites this paper
• Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients.

  2000cites this paper
• A meta-analysis of immunosuppression withdrawal trials in renal transplantation.

  2000cites this paper
• Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.

  2000cites this paper
• Management strategies for nephrotoxicity.

  2000cites this paper
• Immunosuppression in the post-adaptation period.

  2000cites this paper
• Critical threshold of azathioprine dosage for maintenance immunosuppression in kidney graft recipients. Collaborative Transplant Study.

  2000cites this paper
• Short- and long-term post-renal transplant follow-up at Charles Nicolle Hospital.

  1999cites this paper
• The Clinical and Economic Potential of Cyclosporin Drug Interactions

  1999cites this paper
• Minimal standards for reporting clinical trial results in transplantation

  1999cites this paper
• Efficacy and Tolerability of Conversion from Cyclosporin to Azathioprine After Kidney Transplantation

  1998influential citation
• Efficacy and tolerability of conversion from cyclosporin to azathioprine after kidney transplantation: a review of the evidence.

  1998cites this paper
• Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients.

  1998cites this paper
• Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation.

  1998cites this paper
• Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report.

  1998cites this paper
• Randomized trial to evaluate the use of increasing the steroid dose during conversion from cyclosporine to azathioprine.

  1998cites this paper
• Mycophenolate mofetil in cyclosporine-associated nephrotoxicity.

  1998cites this paper
• Oxidative stress in cyclosporin and azathioprine treated renal transplant patients.

  1997cites this paper
• The SAR of UK-78,282 : A novel blocker of human T cell Kv1.3 potassium channels

  1997cites this paper
• Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study.

  1997cites this paper
• Experience with new cyclosporine formulations: Consupren and Neoral in renal transplant patients.

  1997cites this paper
• The Use of Other Drugs to Allow a Lower Dosage of Cyclosporin to Be Used

  1997cites this paper
• Results of 144 consecutive renal transplants from living-related donors.

  1997cites this paper
• The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study.

  1996cites this paper
• A critical review of immunosuppressive regimens.

  1996cites this paper
• The Dialysis Patient and Transplantation

  1996cites this paper
• Mycophenolate mofetil in kidney transplantation.

  1996cites this paper
• Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation.

  1996cites this paper
• Costs of drugs used after renal transplantation

  1996cites this paper
• Oral care planning and handling of immunosuppressed heart, liver, and kidney transplant patients.

  1996cites this paper
• Randomized study with cyclosporine in kidney transplantation: 10-year follow-up.

  1996cites this paper
• Preoperative application of glucocorticosteroids efficaciously reduces the primary immunological response in kidney transplantation

  1996cites this paper
• [Nocardiosis in a renal transplant recipient].

  1996cites this paper
• Conversion from cyclosporin to azathioprine after kidney transplantation.

  1995cites this paper
• Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation.

  1995cites this paper
• Fever and rigors as sole symptoms of azathioprine hypersensitivity.

  1995cites this paper
• Conversion from cyclosporin to azathioprine after kidney transplantation.

  1995cites this paper
• THE RELATION BETWEEN ACUTE VASCULAR AND INTERSTITIAL RENAL ALLOGRAFT REJECTION AND SUBSEQUENT CHRONIC REJECTION

  1995cites this paper
• EFFECT OF OKT3 IN STEROID‐RESISTANT RENAL TRANSPLANT REJECTION

  1995cites this paper
• Changing the regimen.

  1995cites this paper
• Conversion from cyclosporin to azathioprine after kidney transplantation.

  1995cites this paper
• [Problems in long-term follow-up after kidney transplantation].

  1995cites this paper
• AzaThioprine alone is bone sparing and does not alter cyclosporin A‐induced osteopenia in the rat

  1995cites this paper
• Late withdrawal of cyclosporine in stable renal transplant recipients.

  1995cites this paper
• Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment.

  1995cites this paper
• Overview of immunosuppressive therapy in organ transplantation.

  1995cites this paper
• Quality Assurance in Dialysis

  1994cites this paper
• Long-term results with elective cyclosporine withdrawal at three months after renal transplantation--appropriate for living-related transplants.

  1994cites this paper
• Reduction of immunosuppressive therapy after renal transplantation: a randomized study.

  1994cites this paper
• Chronic immunosuppression of the renal transplant patient.

  1994cites this paper
• Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results.

  1994cites this paper
• Pediatric clinical use of the ketoconazole/cyclosporin interaction

  1994cites this paper
• Elective cyclosporine withdrawal 1 year after renal transplantation.

  1994cites this paper
• Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.

  1994cites this paper
• Increased risk of rejection in cyclosporine monotherapy versus combined cyclosporine-steroid immunosuppression in young kidney recipients.

  1994cites this paper
• Quality assurance in renal transplantation

  1994cites this paper
• CYCLOSPORINE‐KETOCONAZOLE INTERACTION: LONG‐TERM FOLLOW‐UP AND PRELIMINARY RESULTS OF A RANDOMIZED TRIAL

  1993cites this paper
• Cyclosporine dosing and its relationship to outcome in pediatric renal transplantation.

  1993cites this paper